我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
181
12 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1957
进行中（未招募）
3
1.7%
已完成
120
66.3%
Enrolling By Invitation
1
0.6%
尚未招募
8
4.4%
招募中
15
8.3%
终止
Unknown
33
18.2%
暂无批准数据
- Mount Sinai and King Saud University Medical City announced a three-year collaboration to study familial inflammatory bowel disease patterns in Saudi families with multiple affected members. - The initiative will collect biospecimens and clinical data to identify exposure and biological markers that drive IBD disease mechanisms and outcomes in high-risk families. - Researchers aim to accelerate development of personalized diagnostics and therapies by combining multi-omics profiling with detailed family pedigrees and clinical histories. - The collaboration seeks to enable earlier risk assessment and more precise treatment strategies for IBD patients worldwide through advanced biomarker discovery.
